Skip to main content

Simson Jake

No open-market purchases or sales filed in the past year.

Current role at each company

  • SEPNSepterna, Inc.Directoras of Jun 30, 2026
  • JANXJanux Therapeutics, Inc.Directoras of Jun 12, 2026
  • PBLSParabilis Medicines, Inc.Directoras of Jun 11, 2026
  • BCAXBicara Therapeutics Inc.Directoras of Jun 10, 2026
  • TYRATyra Biosciences, Inc.Directoras of Jun 1, 2026
Show 1 more company
  • DICEDICE Therapeutics, Inc.Directoras of Aug 9, 2023

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Simson Jake as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

No insider trades match these filters.